Table 1.
Baseline characteristics for 107 subjects.
| N (%) or Mean±SD | |
|---|---|
| Patient Characteristics | |
| Age (Years) | 11.1±3.5 |
| 5–11 | 59 (55%) |
| 12–17 | 48 (45%) |
| Female gender | 48 (45%) |
| Non-Caucasian race (n=97) | 17 (18%) |
| Weight for age Z score (WAZ) (n=106) | 0.56±1.17 |
| Height for age Z score (HAZ) (n=106) | 0.17±1.05 |
| Body Mass Index Z score (BMI Z )(n=106) | 0.60±1.11 |
| BMI Z >2.00 | 10 ( 9%) |
| Percent body fat Z score (n=77) | 0.00±1.15 |
| Fat-free mass Z score (n=80) | 0.01±0.92 |
| Mode of acquisition (n=90) | |
| Maternal-infant | 80 (89%) |
| Transfusion | 8 ( 9%) |
| Sexual contact, intravenous drug use | 2 ( 2%) |
| Genotype (n=106) | |
| 1 | 85 (80%) |
| 2 | 7 ( 7%) |
| 3 | 13 (12%) |
| 6 | 1 ( 1%) |
| Histology Results (n=104) | |
| Histology Activity Index | |
| None | 0 ( 0%) |
| Minimal (1 – 3) | 33 (32%) |
| Mild (4 – 6) | 52 (50%) |
| Moderate (7 – 9) | 17 (16%) |
| Marked (10 – 12) | 2 ( 2%) |
| Steatosis | |
| None | 59 (57%) |
| Minimal (≤ 5% of tissue) | 36 (35%) |
| Mild (6 – 33%) | 9 ( 9%) |
| Fibrosis Score | |
| None | 13 (13%) |
| Portal-Periportal fibrosis (Ishak 1–2) | 86 (83%) |
| Bridging Fibrosis (Ishak 3–4) | 4 ( 4%) |
| Cirrhosis (Ishak 5–6) | 1 ( 1%) |